Elevation Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.1K Hold
66
0.01% 422
2026
Q1
$32.4K Sell
66
-12
-15% -$6.51K 0.01% 298
2025
Q4
$45.2K Buy
78
+1
+1% +$566 0.02% 255
2025
Q3
$37.3K Buy
77
+20
+35% +$9.31K 0.01% 272
2025
Q2
$23.1K Hold
57
0.01% 307
2025
Q1
$28.4K Hold
57
0.01% 285
2024
Q4
$29.7K Buy
57
+7
+14% +$3.85K 0.01% 282
2024
Q3
$30.9K Hold
50
0.01% 269
2024
Q2
$27.6K Sell
50
-14
-22% -$8.02K 0.01% 266
2024
Q1
$37.2K Sell
64
-97
-60% -$54.4K 0.02% 243
2023
Q4
$81.5K Hold
161
0.05% 170
2023
Q3
$81.5K Sell
161
-32
-17% -$17.1K 0.07% 111
2023
Q2
$101K Hold
193
0.08% 101
2023
Q1
$111K Buy
+193
New +$109K 0.1% 92

Other funds holding TMO

Elevation Wealth Partners's TMO Position: Q2 2026 in Review

Elevation Wealth Partners held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 66 shares worth $33.1K. The position accounts for 0.01% of the portfolio, ranked #422.

Elevation Wealth Partners first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $111K in Q1 2023. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Elevation Wealth Partners held 66 shares of Thermo Fisher Scientific worth $33.1K as of Q2 2026.
  • Elevation Wealth Partners left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #422 holding.
  • Elevation Wealth Partners first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Elevation Wealth Partners's Thermo Fisher Scientific position peaked at $111K in Q1 2023.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.